Global Journal of Medical Research, F: Diseases, Volume 22 Issue 4

glycemic control. The Pittsburgh Prospective Insulin- Dependent Diabetes Cohort Study Status Report after 5 years of IDDM. Diabetes Care 1989; 12(10): 694–700. 32. Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998; 18: 352. 9123. 33. Maxhimer JB, Somenek M, Rao G, Pesce CE, Baldwin Jr D, Gattuso P, et al. Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes 2005; 54(7): 2172–8. 34. Hayashida T, Schnaper HW. High ambient glucose enhances sensitivity to TGF- beta1 via extracellular signal-regulated kinase and protein kinase Cdelta activities in human mesangial cells. J Am SocNephrol 2004; 15(8): 2032–41. 35. Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken RA, Hugo CP. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int 2006; 69(9): 1654–61. 36. Barzilay J, Warram J, Bak M, Laffel L, Canessa M, Krolewski A. Predisposition to hypertension: risk factor for nephropathy and hypertensionin IDDM. Kidney Int 1992; 41: 723–30. 37. De Cosmo S, Bacci S, Piras G, Cignarelli M, Placentino G, Margaglione M, et al. High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia 1997; 40: 1191–6. 8 Year 2022 Global Journal of Medical Research Volume XXII Issue IV Version I ( D ) F © 2022 Global Journals To Evaluate the Role of HbA1C as a Predictor for the Development of Diabetic Nephropathy in Type 1 Diabetic Patients